key: cord-0821879-ame6fbof authors: Perfetto, L; Pastrello, C; del-Toro, N; Duesbury, M; Iannuccelli, M; Kotlyar, M; Licata, L; Meldal, B; Panneerselvam, K; Panni, S; Rahimzadeh, N; Ricard-Blum, S; Salwinski, L; Shrivastava, A; Cesareni, G; Pellegrini, M; Orchard, S; Jurisica, I; Hermjakob, H; Porras, P title: The IMEx coronavirus interactome: an evolving map of Coronaviridae–host molecular interactions date: 2020-11-18 journal: Database (Oxford) DOI: 10.1093/database/baaa096 sha: 4c47a8058764a50ea6933f6ba5c511f597a7c2ad doc_id: 821879 cord_uid: ame6fbof The current coronavirus disease of 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus (SARS-CoV)-2, has spurred a wave of research of nearly unprecedented scale. Among the different strategies that are being used to understand the disease and develop effective treatments, the study of physical molecular interactions can provide fine-grained resolution of the mechanisms behind the virus biology and the human organism response. We present a curated dataset of physical molecular interactions focused on proteins from SARS-CoV-2, SARS-CoV-1 and other members of the Coronaviridae family that has been manually extracted by International Molecular Exchange (IMEx) Consortium curators. Currently, the dataset comprises over 4400 binarized interactions extracted from 151 publications. The dataset can be accessed in the standard formats recommended by the Proteomics Standards Initiative (HUPO-PSI) at the IntAct database website (https://www.ebi.ac.uk/intact) and will be continuously updated as research on COVID-19 progresses. Severe acute respiratory syndrome, or SARS, emerged as a life-threatening viral disease of unknown origin in late 2002 in the Guangdong Province of southern China caused by the severe acute respiratory syndrome coronavirus (SARS-CoV) (1) . The SARS-CoV-2 is a related virus responsible for the current outbreak of coronavirus disease of 2019 (COVID-19) (2) . As of September 2020, over 26.5 million people globally have been shown to be infected with the virus, with more than 873 000 deaths directly attributed to its effects (worldometer, https://www.worldometers.info/coronavirus/). To distinguish the strains that caused the SARS outbreak of 2002 from other SARS-related, nonhuman-hosted SARS-CoV strains, we refer to the former as SARS-CoV-1. The COVID-19 pandemic has resulted in massive scientific efforts attempting to fight the disease and understand the biology of the virus. This has resulted in enormous challenges for the research scientist when attempting to find and select information relevant to specific areas of viral biology and pathology. In order to aid the scientific community and expedite drug and vaccine development, multiple data curation efforts have been undertaken to perform a critical assessment of the literature and represent different aspects of the virus and the disease in a structured and computationally accessible manner. One recent example of such efforts is the COVID-19 Disease Map (3), a community effort to capture the intricate aspects of SARS-CoV-2 biology as reusable and interoperable pathway maps, so they can be used in systems biology and modeling pipelines. Identification of virus-host interactions and the analysis of the topological structure of a relevant molecular interaction network are the necessary steps to understand the cellular mechanisms involved in a biological process such as viral infection of a cell. A detailed map of the interactions between human and pathogen proteins will aid in a more complete awareness of the mechanisms of infection and subsequent viral replication, assembly and release and may help to identify novel drug targets, or assist in a rapid and more accurate repurposing of existing drugs for treating or preventing infection. Further to this, such networks can be used to study changes in the transcriptome or proteome of a virally infected cell when compared to normal cells. Co-regulated genes or proteins that also co-cluster in this network may indicate that these entities are involved in the same biological process or are members of the same functional complex. For such a network to be of value to the researcher, a certain amount of metadata needs to be provided, which enables the assessment of network quality and data types. These data need to be supplied in a standardized and computer-accessible format, which allows for scoring, filtering and selection. The International Molecular Exchange (IMEx) Consortium (4) has been providing such data for over 15 years, supplying experimental details using controlled vocabulary terms, captured using a detailed curation model. Important aspects of an interaction experiment are described, including host organism, interaction detection and participant identification methodologies as well as details of the constructs such as binding domains and the effects of site-directed mutations. Current membership of the IMEx Consortium includes the IntAct (5), MINT (6), DIP (7), UniProt (8), MatrixDB (9) and IID (10) data resources, who collaborate to provide the users with a single, consistent viral-host dataset to work with. When a novel virus emerges, as was the case with SARS-CoV-2 in 2019, the study of closely related species, such as SARS-CoV-1 and other coronaviruses, may help with this process, giving the scientific community time to produce species-relevant data. For this reason, the network includes data on all coronaviruses available in the scientific literature. While primarily consisting of protein-protein interaction data, the network also contains interactions with lipids, glycosaminoglycans and RNAs, again curated to IMEx standards. The data are open under a CC-BY 4.0 license and downloadable from the IntAct website and FTP in PSI-MI standard tabdelimited and XML-based formats. A brief description can be found at http://www.ebi.ac.uk/intact/resources/datasets, and a collection of interactive network representations of the dataset at the time of writing is available at http://www. ndexbio.org/#/networkset/4c2268a1-a0f0-11ea-aaef-0ac1 35e8bacf. The dataset will be expanded and updated with every IntAct release. All statistics and details shown on this manuscript are derived from the IntAct database release of 2020-07-11. Complex Portal annotations used in Supplementary Table 4 were also obtained from the same data release. Specific analyses include the following datasets: SARS-CoV Analyses were done using R 4.0.0 (11) and the R data.table package (12) . Venn diagrams were created using ggVennDiagram 0.3 (13) . All other plots were created using ggplot2 3.3.0 (13) and wesanderson (14) packages. The network in Figure 1 was created using NAViGaTOR 3.0.13 (15) ; the data used to create the network are provided in Supplementary Table 5F . The rest of the interactive networks were created using Cytoscape 3.8.0 (16) , and all networks were uploaded to NDEx using Cytoscape. Analysis was performed using TissueEnrich (17) 1.8.0 R package on human protein targets using Protein Atlas (18) expression data. Background was the entire proteome as listed in the UniProtKB website (https: //www.uniprot.org/proteomes/UP000005640). Only hits with a fold change above zero are shown. Log10 P-value was zero for all tissues. Full data are available in Supplementary Table 3 . Pathway enrichment analysis was performed using pathDIP 4 (19) API in R, with literature curated set. Only pathways with false discovery rate (FDR) < 0.01 (Benjamini Hochberg (BH)-method) were considered. As the majority of enriched pathways (75% for SARS-CoV-1, 80% for SARS-CoV-2, 72% for Gordon_LT, 76% for Li_LT and 55% for Stukalov_LT) were from Reactome database (20) , we further organized them using level-one Reactome ontology to create the figure. All enriched pathways are listed in Supplementary Table 2 , and pathways present in multiple sets are highlighted in the 'overlap' tab. For network annotation, each protein was linked to the pathway it is part of with the lowest FDR (BH-method) and annotated with level-one Reactome ontology according to such pathway. When a protein was annotated with two different level-one terms (this happened only for 58 targets in common between SARS-CoV-1 and SARS-CoV-2), only the SARS-CoV-2 level-one term was used. As of August 2020, the dataset contains 3735 unique interacting molecule pairs, represented in 4479 binarized interactions extracted from 151 publications, 8 of which are preprints from bioRxiv. The entire 'coronavirus dataset' can be downloaded from the FTP site in PSI-MI standard XML-based formats: PSI-MI XML 2.5 and 3.0 (format documentation available at https://psicquic. github.io/PSIMIXML.html). Each file corresponds to one publication in the coronavirus dataset. In addition to the XML format, the data can also be browsed on the IntAct webpage (www.ebi.ac.uk/intact/query/annot:"data set:coronavirus"), where it is available for download in additional formats, such as the tab-delimited PSI-MI-TAB 2.7 (format documentation available at https://psic quic.github.io/MITAB27Format.html). Viral specific interactomes can also be retrieved using MIQL syntax. For example, to filter for human-SARS-CoV-2 interactions, the string 'taxid:2697049 AND taxid:9606' can be used in the search box. A snapshot of the coronavirus dataset hosted in IntAct at the time of writing is also available as a collection of interactive network representations in the NDEx archive. Here, we submitted five networks, each highlighting a key aspect of the dataset: network description and in Supplementary 'methods' section. Using the same search strings as on the IntAct website, the data can also be accessed via the PSICQUIC (21) API, the IMEx Consortium webpage (www.imexconsorti um.org) and the VirusMentha (22) Table 1D . Figure 1 shows SARS-CoV-2-and SARS-CoV-1-human interactions, separating human targets that are specific for one or the other coronavirus or in common between the two, also highlighting affected pathways. IMEx Consortium curators have collated interaction evidence from scientific articles and preprints using the following selection criteria: This results in the inclusion of data from apparently irrelevant species (e.g. yeast) that is of interest from the phylogenetic and evolutionary point of view. (iv) Preprints are considered and, if deemed appropriate, curated when containing SARS-CoV-2 data, an exception to IMEx practice of representing only peer-reviewed research. This reflects the interest these data have engendered during the pandemic. These datasets are clearly marked as prepublication and will be re-curated, if necessary, when published. The IMEx curation model captures the details of specific constructs used for the detection of interactions. This allows for the representation of different constructassociated features, such as specific mutations affecting interaction outcome (23) or sequence regions that are associated with binding. Most of these in-depth studies are centered around the Spike-ACE2 interaction for SARS-CoV-2 and SARS-CoV-1. The only other SARS-CoV-2 mutation reported so far is Nsp5/3C-like proteinase p.Cys145Ala catalytically inactive mutant, which exhibits an interaction profile different from the canonical form in an affinity purification and mass spectrometry (AP-MS) study (24) . There are a few other mutations reported for SARS-CoV-1 and in other members of the Coronaviridae family, but it is clear that specific variation effects on coronavirus-related interactions is an area requiring extensive exploration. As shown in Figure 2A , fragment constructs have been used in more studies than mutations, although some of these might have been designed for convenience reasons (e.g. constructs that are easier to express in heterologous systems). Interactive network representations highlighting mutations and binding regions can be found in https://doi.org/10.18119/N9W590 and in https://doi.org/10.18119/N90W3W. Regarding interaction data generation approaches, the experimental setup used to detect an interaction is summarized by three key fields in the IMEx curation model: the method used to determine that an interaction is happening ('interaction detection method'), the method used to determine which molecules are involved ('participant detection method') and the biological environment in which the interaction occurs ('host organism'). Each of these is described by an appropriate controlled vocabulary term, making the data readily searchable. In the coronavirus dataset, the overwhelming majority of data were generated by AP-MS approaches performed in A549, HEK293(T) or HeLa cells (Supplementary Table 1B ). This type of data produces sets of potential interacting partners (preys) associated with a bait of interest but does not directly identify binary interacting partners. Also, the data needs to be automatically expanded into binaries for its representation in tabular or network graph form. This accounts for a large proportion of binary interactions from spoke-expanded n-ary relationships found in the dataset: 3267 out of 4477 interactions (73%) are expanded n-ary relationships, while only 41% of the binary interactions found in the full IntAct database are expanded n-ary relationships. Most content has been curated after declaration of the COVID-19 pandemic on 11 March 2020 ( Figure 2) . The data growth timeline shows four jumps in interaction numbers, three for SARS-CoV-2 and one for SARS-CoV-1, due to curation of HT studies not available for other Coronaviridae ( Figure 3A ). This is also reflected in the pattern of data growth regarding detailed information about mutations and binding regions (Figure 2A ). The plots also illustrate that at this point there are more studies dealing with detailed interaction data for SARS-CoV-1, a situation that will likely change as more SARS-CoV-2 studies are performed. Interaction data are derived from both, small-scale studies focused on one or just a few interactions (LT) and large-scale screenings able to detect hundreds or thousands of interactions in a single experiment (HT). The extreme urgency in the study of SARS-CoV-2 has resulted in a strong dominance of HT data for this species in comparison with the other members of Coronaviridae reported in the dataset ( Figure 3A) . Additionally, SARS-CoV-2 smallscale studies are mainly focused around the ACE2-Spike interaction due to its relevance for virion recognition and infection. Lack of overlap between different HT interaction datasets is a long-recognized phenomenon, since different experimental approaches are better suited to detect interactions featuring specific physicochemical characteristics and protein abundances, among other parameters (27) (28) (29) . Even in this case, where the approach used is broadly similar, they likely reflect methodological differences. AP-MS datasets are very sensitive to protein abundances and affinities, as well as to the selection and orientation of tags and Development of the IMEx coronavirus dataset complements other curation efforts that have been initiated in the light of the pandemic. Interaction resources BioGRID (31) and VirHostNet (the latter specialized in virus-host interaction data) (32) have produced shallow curation interaction datasets taken from COVID-19-related literature. The IMEx Coronavirus dataset has been used by the DisGeNET database (33) for contextual annotation with related disea ses (https://www.disgenet.org/downloads#section9). Also, members of the IMEx Consortium are involved in the COVID-19 Disease Map initiative (https://covid.pages.uni .lu/), where interaction information from the dataset is guiding COVID-19-related pathway curation. As an example, the list of PMIDs from IMEx Coronavirus dataset has and Stukalov_LT (Stukalov plus low throughput) datasets. Enrichment was performed using pathDIP (a database integrating 24 different pathway databases). Only human proteins were considered. The majority of enriched pathways were from Reactome database, so a mapping of each Reactome pathway to the parent pathway ontology was performed, and the heat map shows the percentage of pathways in each parent pathway over the total of pathways. been used to screen papers containing causal interactions to build COVID-19 causal nobreaknetwork perturbed during SARS-COV2 infection by the SIGNOR 2.0 resource (34) (https://signor.uniroma2.it/covid/) and to select the Gordon et al. human interactors to integrate in the SIGNOR 2.0 network. We are also involved in a parallel effort of curating protein complexes from SARS-CoV-1, SARS-CoV-2, MERS-CoV as well as their human target complexes in the Complex Portal (https://www.ebi.ac.uk/complexportal), linking to available experimental interaction evidence in IntAct when possible. This initiative is especially relevant because, as previously stated, coronaviruses increase the number of functional proteins produced by the viral genome by posttranslational cleavage of long polypeptide transcripts. The functionality and/or stability of these proteins are further increased through the formation of protein complexes, all of which have been catalogued into the Complex Portal. To date, 14 complexes have been identified in each strain, formed by viral-viral protein interactions, including homomeric assemblies such as the dimeric SARS-CoV-2 main protease complex (CPX-5685). Other reference entities such as the SARS-CoV-2 Spike-human ACE2 receptor complex (CPX-5683) have also been created to enable their identification in large omics datasets. All complexes have been annotated with Gene Ontology terms, describing their role in the virus lifecycle, which again will assist in the analysis of large omics-derived datasets. Accurate and detailed representation of biological insight into public databases is a fundamental source of data for scientific discovery, even more so in a situation of accelerated research work such as the current pandemic. Our curation of molecular interactions related to Coronaviridae enables a systematic perspective of this data and greatly increases its interoperability. From our overview analysis of the data available so far, we can highlight how the SARS-CoV-2 data seem to be both biologically relevant, and thus informative for research on the disease, and strongly preliminary, so full consideration for its inherent incompleteness should be given when using it. The IMEx Consortium is expanding the resource as new data become available, striving to provide the most accurate possible picture of the Coronaviridae interactome. from Ontario Research Fund (#34876), Natural Sciences Research Characterization of a novel coronavirus associated with severe acute respiratory syndrome A new coronavirus associated with human respiratory disease in China COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms Protein interaction data curation: the International Molecular Exchange (IMEx) consortium The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases MINT, the molecular interaction database: 2012 update DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions UniProt: a worldwide hub of protein knowledge MatrixDB: integration of new data with a focus on glycosaminoglycan interactions Integrated interactions database: tissue-specific view of the human and model organism interactomes R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing 2019) data.table: extension of 'data ggVennDiagram: A "ggplot2" Implement of Venn diagram Wesanderson: a Wes Anderson Palette Generator NAViGa-TOR: network analysis, visualization and graphing Toronto Cytoscape: a software environment for integrated models of biomolecular interaction networks TissueEnrich: tissue-specific gene enrichment analysis Proteomics. Tissue-based map of the human proteome 2020) pathDIP 4: an extended pathway annotations and enrichment analysis resource for human, model organisms and domesticated species The reactome pathway knowledgebase A new reference implementation of the PSICQUIC web service VirusMentha: a new resource for virus-host protein interactions Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV Systems Biology Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis Proteinprotein interaction networks: the puzzling riches An empirical framework for binary interactome mapping Maximizing binary interactome mapping with a minimal number of assays Complex Portal 2018: extended content and enhanced visualization tools for macromolecular complexes The BioGRID interaction database: 2019 update VirHost-Net 2.0: surfing on the web of virus/host molecular interactions data Dis-GeNET: a comprehensive platform integrating information on human disease-associated genes and variants SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update The authors would like to thank Dr Yun Niu for assistance in pathway reduction analysis, Dr Serene Wong for useful discussion and Dr Rudolf Pillich for his help with NDEx networks upload and refinement. The IntAct and Complex Portal databases and EMBL-EBI-based authors received funding from EMBL core funding, Open Targets Supplementary data are available at Database Online.